Taxpayers — not Big Pharma — have funded the research behind new drugs
Something odd happened when the Trump administration submitted the original version of its latest pro-corporate budget: Big Pharma didn’t like it. The problem wasn’t a tax hike or new regulations: the problem was that the budget included deep cuts to the budget of the National Institutes of Health. If those cuts had gone through, they would have exposed… Read more…
